Circular Genomics Sees More Direct PGx Assay Through Brain-Derived Circular RNA

jaya40436
Jun 5, 2023
1 min read

Updated: Jul 23, 2024

NEW YORK, NY., June 05, 2023 (GenomeWeb) -- Molecular diagnostics startup Circular Genomics sees a more direct way to predict patient response to psychiatric medications by analyzing circular RNA (circRNA) molecules that brain cells shed into the bloodstream.

View Remaining Article at GenomeWeb

Paul Sargeant, PhD, CEO of Circular Genomics Presents at LSI USA '25 - "Circular RNA Biomarkers for Depression Treatment"

Circular Genomics is at the forefront of revolutionizing healthcare by leveraging circular RNA to develop advanced diagnostic tools,...

5 Promising RNA Biotech Companies To Watch in 2025

Circular Genomics: Innovative RNA Solutions to Lead a New Era in Mental Health RNA, often referred to as the “messenger molecule,” plays...

Podcast: "Revolutionizing Depression Treatment with Dr. Nikolaos Mellios"

Circular Genomics' Chief Scientific Officer, Dr. Nikolaos Mellios, M.D., PhD, joins Steven Schwartz on the Concierge Medical Marketing...

Commentaires

Les commentaires sur ce post ne sont plus acceptés. Contactez le propriétaire pour plus d'informations.